Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...

ENERGIF-703 is under clinical development by Energenesis Biomedical and currently in Phase III for Diabetic Foot Ulcers.

Objective We examined associations between ulcer bioburden and ulcer outcomes in neuropathic diabetic foot ulcers (DFUs) that lacked clinical signs of infection. Research Design and Methods Three ...

Lameness is a severe issue that is obvious in a lot of herds in the country with grazing herds experiencing difference issues ...

Diabetic Foot Disease is defined as a syndrome in which peripheral neuropathy and peripheral vascular disease may result in foot ...

Most diabetic wound care products are passive dressings, only providing a protective barrier against the external environment ...

Most of us suffer some kind of mild reaction after taking prescription and nonprescription medication. But in some cases, the ...

Nurse Riham Awad roams daily among the tents of displaced persons in the Mawasi area of Khan Yunis, in southern Gaza, to ...

Onychodystrophy of the toenails. Leg ulcers on the lateral (A) and medial (B) aspects of the right leg 1 year after IM testosterone and local treatment showing a reduction in the diameter and ...

Sometimes, this protective mechanism breaks down leading to the development of a raw area or ulcer in wall of the intestine. The majority of ulcers develop in the part of the gut just after the ...